Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma-Reference-Cited by-同舟云学术

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma

Published:2016-03-28 Issue:6 Volume:5 Page:e1164919
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kroesen Michiel,Büll Christian,Gielen Paul R.,Brok Ingrid C.,Armandari Inna,Wassink Melissa,Looman Maaike W. G.,Boon Louis,den Brok Martijn H.,Hoogerbrugge Peter M.,Adema Gosse J.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1164919

Reference58 articles.

1. Neuroblastoma

2. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

3. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

4. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

5. Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies;Biomedicine & Pharmacotherapy;2024-09

2. Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma;Cancers;2024-08-17

3. Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk Neuroblastoma;Cancers;2024-05-30

4. Immunotherapy Options for Neuroblastoma: What is on the Horizon?;Current Molecular Biology Reports;2024-05-13

5. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15